Join
Live feed
·
INSIDERFilingvia Quantisnow
Alexion Pharmaceuticals, Inc. logo

SEC Form 4: Brennan David R returned 20,873 units of Common Stock to the company, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
ALXN· Alexion Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALXN (Alexion Pharmaceuticals, Inc.) and more on Quantisnow.